Compounding Interest

In this episode of Compounding Interest: The Business of Personalized Medicine, host Amy Summers sits down with Ndidiamaka “Didi” Okpareke , pharmacist, president and owner of Olive Tree Compounding Pharmacy , and congressional candidate in New Mexico, for an inspiring conversation about entrepreneurship, healthcare policy, leadership, and the courage to pursue unexpected opportunities. From her f...

In this episode of Compounding Interest: The Business of Personalized Medicine, host Amy Summers sits down with Joel Gajewski to explore the business side of compounding pharmacy. Drawing on more than 20 years in advertising and sales, Joel shares how lessons in scaling teams, adapting to change, specializing in profitable niches, and delivering exceptional customer service helped MediVera expand...

What happens when one of Pittsburgh’s oldest pharmacies combines more than 160 years of history with modern personalized medicine? In this episode of Compounding Interest: The Business of Personalized Medicine, host Amy Summers sits down with Rosemary Mihalko, owner of Hieber’s Pharmacy. Rosemary shares how she has preserved the pharmacy’s historic roots while transforming it into a modern compoun...

In this episode of Compounding Interest: The Business of Personalized Medicine, host Amy Summers sits down with fourth-generation pharmacist Christian Stella to explore how compounding has evolved from the neighborhood pharmacies of the early 1900s into a technology-enabled industry serving telehealth companies and patients at scale. Christian draws parallels between the pharmaceutical industriali...

What does a career in compounding pharmacy look like when you start as a technician and refuse to see that title as a ceiling? In this episode of Compounding Interest: The Business of Personalized Medicine, host Amy Summers sits down with Ashley Barton to explore the evolving role of pharmacy technicians in compounding. Ashley shares how she progressed from working as a technician during college t...

As personalized medicine continues to expand; from GLP-1 therapies and peptides to hormone replacement therapy, the demand placed on compounding pharmacies has never been greater. While personalized care has traditionally relied on manual sterile compounding, increasing regulatory expectations, workforce shortages, and production demands are driving a major shift toward automation. In this episode...

Compounding pharmacies have rapidly moved from a niche corner of healthcare into the national spotlight, driven largely by the demand for GLP-1 medications and growing interest in personalized medicine. In this episode of Compounding Interest: The Business of Personalized Medicine, host Amy Summers sits down with Jesse Vidrine, President of Boudreaux's New Drugstore and Vidrine Pharmaceutical Grou...

The personalized medicine and compounding pharmacy industry is evolving rapidly as patient demand, regulatory scrutiny, and technological innovation continue to collide. In this episode of Compounding Interest: The Business of Personalized Medicine, host Amy Summers sits down with Darshan Kulkarni to explore the legal and ethical challenges facing compounding pharmacies today. From FDA advertising...

The future of peptide compounding is at a critical crossroads. As the FDA prepares for its upcoming Pharmacy Compounding Advisory Committee (PCAC) meeting, compounders, prescribers, patients, and industry advocates are facing important decisions that could shape access to peptide therapies for years to come. In this episode, Amy Summers sits down with Melissa Stefko of Wells Pharmacy Network to di...

Are you overwhelmed by complex compliance codes and shifting regulatory standards? Do you worry that your quality management systems are just checking boxes instead of truly safeguarding your operations? You don't have to navigate the high-stakes landscape of sterile compounding and personalized medicine alone. Introducing Compounding Interest: The Business of Personalized Medicine! Brought to you...